• Jazz Pharmaceuticals EPS for the quarter ending March 31, 2025 was $-1.52, a 560.87% increase year-over-year.
• Jazz Pharmaceuticals 2024 annual EPS was $8.65, a 41.8% increase from 2023.
• Jazz Pharmaceuticals 2023 annual EPS was $6.1, a 270.39% decline from 2022.
• Jazz Pharmaceuticals 2022 annual EPS was $-3.58, a 35.14% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.